EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 147 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $89,936 | -91.5% | 5,703 | -89.5% | 0.00% | -100.0% |
| Q2 2023 | $1,060,238 | +459.1% | 54,539 | +716.0% | 0.00% | – |
| Q1 2023 | $189,625 | +35.9% | 6,684 | +40.0% | 0.00% | – |
| Q4 2022 | $139,515 | +13.4% | 4,773 | +1.9% | 0.00% | – |
| Q3 2022 | $123,000 | -48.5% | 4,684 | -12.8% | 0.00% | – |
| Q2 2022 | $239,000 | -27.1% | 5,373 | -18.8% | 0.00% | – |
| Q1 2022 | $328,000 | -12.5% | 6,620 | -10.1% | 0.00% | – |
| Q4 2021 | $375,000 | -3.1% | 7,360 | +6.2% | 0.00% | – |
| Q3 2021 | $387,000 | -6.1% | 6,932 | -27.9% | 0.00% | – |
| Q2 2021 | $412,000 | +11.4% | 9,616 | +8.5% | 0.00% | – |
| Q1 2021 | $370,000 | -16.3% | 8,860 | -6.6% | 0.00% | – |
| Q4 2020 | $442,000 | +27.4% | 9,488 | +16.3% | 0.00% | – |
| Q3 2020 | $347,000 | -11.9% | 8,155 | -0.8% | 0.00% | – |
| Q2 2020 | $394,000 | -19.9% | 8,217 | -23.2% | 0.00% | – |
| Q1 2020 | $492,000 | -54.6% | 10,693 | -40.7% | 0.00% | -100.0% |
| Q4 2019 | $1,083,000 | +14.6% | 18,045 | +7.9% | 0.00% | 0.0% |
| Q3 2019 | $945,000 | +11.8% | 16,731 | +9.9% | 0.00% | – |
| Q2 2019 | $845,000 | +35.4% | 15,221 | +22.8% | 0.00% | – |
| Q1 2019 | $624,000 | +3.7% | 12,398 | -17.4% | 0.00% | – |
| Q4 2018 | $602,000 | -90.7% | 15,001 | -84.0% | 0.00% | -100.0% |
| Q3 2018 | $6,490,000 | +44.5% | 93,632 | +57.7% | 0.00% | +100.0% |
| Q2 2018 | $4,491,000 | +24.9% | 59,362 | -13.0% | 0.00% | -50.0% |
| Q1 2018 | $3,595,000 | +223.6% | 68,256 | +227.9% | 0.00% | +100.0% |
| Q4 2017 | $1,111,000 | -83.0% | 20,816 | -81.0% | 0.00% | -75.0% |
| Q3 2017 | $6,546,000 | -2.5% | 109,800 | +29.0% | 0.00% | -20.0% |
| Q2 2017 | $6,713,000 | +284.9% | 85,107 | +304.3% | 0.01% | +400.0% |
| Q1 2017 | $1,744,000 | -12.1% | 21,049 | -15.8% | 0.00% | -50.0% |
| Q4 2016 | $1,983,000 | -63.4% | 25,009 | -67.7% | 0.00% | -50.0% |
| Q3 2016 | $5,423,000 | +107.2% | 77,501 | +14.8% | 0.00% | +100.0% |
| Q2 2016 | $2,617,000 | +179.6% | 67,501 | +191.7% | 0.00% | +100.0% |
| Q1 2016 | $936,000 | -60.4% | 23,140 | -13.1% | 0.00% | -50.0% |
| Q4 2015 | $2,361,000 | -25.0% | 26,635 | -37.4% | 0.00% | 0.0% |
| Q3 2015 | $3,147,000 | +90.2% | 42,527 | +107.6% | 0.00% | +100.0% |
| Q2 2015 | $1,655,000 | +9094.4% | 20,484 | +1607.0% | 0.00% | – |
| Q4 2014 | $18,000 | -87.3% | 1,200 | -88.0% | 0.00% | – |
| Q2 2014 | $142,000 | +1477.8% | 9,985 | +1134.2% | 0.00% | – |
| Q1 2014 | $9,000 | – | 809 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 113,737 | $3,227 | 0.98% |
| Smith, Graham & Co., Investment Advisors, LP | 236,883 | $6,720,371 | 0.82% |
| Capital Impact Advisors, LLC | 13,607 | $386,031 | 0.47% |
| TANG CAPITAL MANAGEMENT LLC | 80,000 | $2,269,600 | 0.34% |
| BRANDES INVESTMENT PARTNERS, LP | 545,050 | $15,463,069 | 0.33% |
| Watershed Asset Management, L.L.C. | 9,496 | $269,402 | 0.33% |
| Jackson Creek Investment Advisors LLC | 25,164 | $714 | 0.30% |
| SummerHaven Investment Management, LLC | 18,178 | $515,710 | 0.30% |
| Virtus Fund Advisers, LLC | 1,117 | $31,689 | 0.22% |
| Virtus Investment Advisers, Inc. | 7,308 | $207,328 | 0.14% |